framycetin has been researched along with Conductive Hearing Loss in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crysdale, WS; Forte, V; Hui, Y; Park, A | 1 |
Brownlee, RE; Hulka, GF; Pillsbury, HC; Prazma, J | 1 |
2 other study(ies) available for framycetin and Conductive Hearing Loss
Article | Year |
---|---|
Ototoxicity from ototopical aminoglycosides.
Topics: Administration, Topical; Adolescent; Anti-Bacterial Agents; Anti-Inflammatory Agents; Audiometry, Pure-Tone; Dexamethasone; Drug Therapy, Combination; Framycetin; Gentamicins; Gramicidin; Hearing Loss, Conductive; Humans; Male; Otitis Media with Effusion; Tympanic Membrane Perforation | 1997 |
Ciprofloxacin. Use as a topical otic preparation.
Topics: Administration, Topical; Animals; Auditory Threshold; Ciprofloxacin; Ear, Inner; Evoked Potentials, Auditory, Brain Stem; Female; Guinea Pigs; Hair Cells, Auditory; Hearing Loss, Conductive; Neomycin; Sodium Chloride | 1992 |